• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-
1) of almost 5 million adults insured between 1934 and 1954, a strong direct relationship …

W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …

Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …

This article is a comprehensive document on the diagnosis and management of
fibromuscular dysplasia (FMD), which was commissioned by the working group …

Background Atherosclerotic renal-artery stenosis is a common problem in the elderly.
Despite two randomized trials that did not show a benefit of renal-artery stenting with respect …

Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …

Most patients with hypertension have no clear etiology and are classified as having primary
hypertension. However, 5% to 10% of these patients may have secondary hypertension …

Olin et al Fibromuscular Dysplasia 1049 stenosis. However, it was not until Palubinskas and
Wylie, 9 Hunt, 10 and Kincaid and Davis11 described in 1961 the arteriographic and clinical …